The DOI matches its Crossref record.
Identification and Characterization of Human Endometase (Matrix Metalloproteinase-26) from Endometrial Tumor
Open accessAbstract
We report the discovery, cloning, and characterization of a novel human matrix metalloproteinase 26 (MMP-26) (matrixin) gene, endometase, an endometrial tumor-derived metalloproteinase. Among more than three million expressed sequence tags sequenced, the endometase gene was only obtained from human endometrial tumor cDNA library. Endometase mRNA was expressed specifically in human uterus, not in other tissues/cells tested, e.g. testis, heart, brain, lungs, liver, thymus, and melanoma G361. Endometase protein has a signal peptide, a propeptide domain, and a catalytic domain with a unique "cysteine switch" propeptide sequence, PHCGVPDGSD, and a zinc-binding motif, VATHEIGHSLGLQH. Endometase is 43, 41, 41, and 39% identical to human metalloelastase, stromelysin, collagenase-3, and matrilysin, respectively. The zymogen was expressed and isolated from Escherichia coli as inclusion bodies with a molecular mass of 28 kDa. The identity and homogeneity of the recombinant protein was confirmed by protein N-terminal sequencing, silver stain, and immunoblot analyses. The pro-enzyme was partially activated during the folding process. Endometase selectively cleaved type I gelatin and alpha(1)-proteinase inhibitor; however, it did not digest collagens, laminin, elastin, beta-casein, plasminogen, soybean trypsin inhibitor, or Bowman-Birk inhibitor. It hydrolyzed peptide substrates of matrixins and tumor necrosis factor-alpha converting enzyme. Endometase may selectively cleave extracellular matrix proteins, inactivate serpins, and process cytokines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Visse, R., & Nagase, H. (2003) · Circulation Research · doi:10.1161/01.res.0000070112.80711.3d · Cited by 4,575
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
“MMP7 and MMP26 merely lack these extra domains, whereas MMP23 has unique cysteine-rich, proline-rich, and IL-1 type II receptor-like domains instead of a hemopexin domain (Gururajan et al. 1998, Park et al. 2000).”
BackgroundMatrix metalloproteinases: they're not just for matrix anymore!
McCawley, L. J., & Matrisian, L. M. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00248-9 · Cited by 1,274
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
Role of the sclera in the development and pathological complications of myopia
McBrien, N. (2003) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(02)00063-0 · Cited by 616
The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review
Mehana, E.-S. E., Khafaga, A. F., & El-Blehi, S. S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116786 · Cited by 541
Matrix Metalloproteinases in Lung: Multiple, Multifarious, and Multifaceted
Greenlee, K. J., Werb, Z., & Kheradmand, F. (2007) · Physiological Reviews · doi:10.1152/physrev.00022.2006 · Cited by 474
Itoh, Y. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4782 · Cited by 399
Matrix metalloproteinases in lung biology
Parks, W. C., & Shapiro, S. D. (2000) · Respiratory Research · doi:10.1186/rr33 · Cited by 380
Matrix metalloproteinases in tumor progression: focus on basal and squamous cell skin cancer
Kerkelä, E., & Saarialho‐Kere, U. (2003) · Experimental Dermatology · doi:10.1034/j.1600-0625.2003.120201.x · Cited by 345
Human endothelial gelatinases and angiogenesis
Nguyen, M. (2001) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(01)00007-3 · Cited by 300
Cauwe, B., & Opdenakker, G. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.501783 · Cited by 299
Lohi, J., Wilson, C. L., Roby, J. D., & Parks, W. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m001599200 · Cited by 273
Matrix Metalloproteinases on Skin Photoaging
Feng, C., Chen, X., Yin, X., Jiang, Y., & Zhao, C. (2024) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.16558 · Cited by 112
Llano, E., Pendás, A. M., Aza-Blanc, P., Kornberg, T. B., & López-Otı́n, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006045200 · Cited by 104
RetractedCollagenase‐2 (MMP‐8) and matrilysin‐2 (MMP‐26) expression in human wounds of different etiologies
Pirilä, E., Korpi, J. T., Korkiamäki, T., Jahkola, T., Gutierrez‐Fernandez, A., Lopez‐Otin, C., Saarialho‐Kere, U., Salo, T., & Sorsa, T. (2007) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2006.00184.x · Cited by 92
“MMP-26 can cleave fibronectin, vitronectin, fibrinogen, type IV collagen, gelatin, a2macroglobulin, and a1-proteinase inhibitor in vitro.(12,13) MMP-26 can also activate proMMP-9, facilitating the cleavage of fibronectin.”
Background
Metadata
- Authors
- Park, H. I., Ni, J., Gerkema, F. E., Liu, D., Belozerov, V. E., & Sang, Q.-X. A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-07
- Volume
- 275
- Issue
- 27
- Pages
- 20540-20544
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2084130123
- Cited by
- 195
- References
- 0
- FWCI
- 8.41
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.